Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. Reply

N Engl J Med. 2019 Oct 17;381(16):1596-1597. doi: 10.1056/NEJMc1910735.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Indoles
  • Lung Diseases, Interstitial*
  • Scleroderma, Systemic*

Substances

  • Indoles
  • nintedanib